Our IR sites are designed to be fully compliant with SEC and regulatory agency mandates.
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops gene therapy products for inherited orphan ophthalmology diseases ...
People also ask
What happened to AGTC shares?
What is going on with AGTC?
Should I tender my AGTC shares?
Who bought AGTC?
A live webcast will be available in the Events and Presentations section of AGTC's Investor Relations site at http://ir.agtc.com/events-and-presentations.
Jun 9, 2022 · Seeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects.
Missing: relations | Show results with:relations
Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
The Investor Relations website contains information about AGNC Investment Corp.'s business for stockholders, potential investors, and financial analysts.
Nov 3, 2022 · I am writing today urging you to tender your shares of AGTC common stock in the tender offer. Our board of directors unanimously voted in favor ...
Missing: relations | Show results with:relations
People also search for
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
Applied Genetic Technologies (AGTC) stock investors activity – investors allocate an average of 2.89% to AGTC, based on 604997 active investor portfolios.
Missing: relations | Show results with:relations
Applied Genetic Technologies (AGTC) Investor Presentation - Slideshow · Applied Genetic Technologies Corporation's (AGTC) CEO Sue Washer on Q2 2022 Results - ...
Missing: relations | Show results with:relations
IR CONTACT: David Carey. Lazar FINN Partners. T: (212) 867-1768. david.carey@finnpartners.com · Corporate Contacts: Jonathan Lieber. Chief Financial Officer.
Missing: relations | Show results with:relations